617: The CEO of Merck on Race, Leadership, and High Drug Prices
0:00 -:--
Speed
++++++
PermalinkShare linkShare link with timestamp
February 19, 2018
Kenneth Frazier, the CEO of the pharmaceutical company known as MSD outside of North America, discusses his upbringing and how it influences his leadership as chief executive. He is one of the few African-American CEOs in the Fortune 500, and shot to prominence after resigning from a council advising the Trump White House. Frazier discusses the importance of values in leadership and how Merck thinks about R&D and drug prices.